Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.32
(3.23%)
AUD 0.32
(3.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -65.11 Million AUD | -9.96% |
| 2023 | -59.21 Million AUD | -25.96% |
| 2022 | -47.01 Million AUD | -11.02% |
| 2021 | -42.34 Million AUD | -149.66% |
| 2020 | -16.96 Million AUD | -42.0% |
| 2019 | -11.94 Million AUD | -33.8% |
| 2018 | -8.92 Million AUD | -45.76% |
| 2017 | -6.12 Million AUD | -41.81% |
| 2016 | -4.31 Million AUD | -174.61% |
| 2015 | -1.57 Million AUD | -579.51% |
| 2014 | -231.43 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -49.89 Million AUD | 0.0% |
| 2024 Q4 | -14.96 Million AUD | 0.0% |
| 2024 FY | -64.49 Million AUD | -8.91% |
| 2023 Q4 | -26.91 Million AUD | 0.0% |
| 2023 Q2 | -32.29 Million AUD | 0.0% |
| 2023 FY | -59.21 Million AUD | -25.96% |
| 2022 Q4 | -19.75 Million AUD | 0.0% |
| 2022 FY | -47.01 Million AUD | -11.02% |
| 2022 Q2 | -27.25 Million AUD | 0.0% |
| 2021 FY | -42.34 Million AUD | -149.66% |
| 2021 Q4 | -21.49 Million AUD | 0.0% |
| 2021 Q2 | -20.84 Million AUD | 0.0% |
| 2020 Q4 | -11.04 Million AUD | 0.0% |
| 2020 Q2 | -5.91 Million AUD | 0.0% |
| 2020 FY | -16.96 Million AUD | -42.0% |
| 2019 Q2 | -4.4 Million AUD | 0.0% |
| 2019 FY | -11.94 Million AUD | -33.8% |
| 2019 Q4 | -7.51 Million AUD | 0.0% |
| 2018 Q2 | -3.57 Million AUD | 0.0% |
| 2018 Q4 | -2.67 Million AUD | 0.0% |
| 2018 FY | -8.92 Million AUD | -45.76% |
| 2017 Q2 | -2.81 Million AUD | 0.0% |
| 2017 FY | -6.12 Million AUD | -41.81% |
| 2017 Q4 | -1.48 Million AUD | 0.0% |
| 2016 Q4 | -1.6 Million AUD | 0.0% |
| 2016 FY | -4.31 Million AUD | -174.61% |
| 2016 Q2 | -1.42 Million AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 Q4 | -962.36 Thousand AUD | 0.0% |
| 2015 FY | -1.57 Million AUD | -579.51% |
| 2015 Q2 | -610.27 Thousand AUD | 0.0% |
| 2014 FY | -231.43 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | -1137.499% |
| Acrux Limited | -9.83 Million AUD | -562.113% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -342.944% |
| BTC Health Limited | 1.05 Million AUD | 6270.092% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -428.951% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | -45.338% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 232.481% |
| Biome Australia Limited | -1.91 Million AUD | -3303.242% |
| Hexima Limited | -1 Million AUD | -6354.739% |
| Immutep Limited | -44.93 Million AUD | -44.896% |
| Memphasys Limited | -2.7 Million AUD | -2307.995% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 128.816% |
| Noxopharm Limited | -7.53 Million AUD | -764.13% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -806.045% |
| Race Oncology Limited | -13.38 Million AUD | -386.618% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | -37.921% |
| Starpharma Holdings Limited | -15.15 Million AUD | -329.528% |
| Tissue Repair Ltd | -4.87 Million AUD | -1235.374% |
| Biotron Limited | -5.15 Million AUD | -1164.027% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -232.176% |
| CSL Limited | 5.64 Billion AUD | 101.153% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 770.115% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -4362.407% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -2026.138% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -996.491% |
| Patrys Limited | -3.53 Million AUD | -1739.769% |
| Orthocell Limited | -11.68 Million AUD | -457.414% |
| Imugene Limited | -140.93 Million AUD | 53.798% |
| PYC Therapeutics Limited | -38.85 Million AUD | -67.568% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -800.391% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -639.246% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -805.21% |
| Nanollose Limited | -1.24 Million AUD | -5109.704% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -2951.713% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -3066.073% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -1371.471% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -2165.732% |
| Nyrada Inc. | -4.56 Million AUD | -1327.795% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | -159.827% |
| PharmAust Limited | -6.65 Million AUD | -877.862% |
| AnteoTech Limited | -11.72 Million AUD | -455.252% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | -195.277% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -1318.817% |
| Actinogen Medical Limited | -12.83 Million AUD | -407.144% |
| Immuron Limited | -5.8 Million AUD | -1022.407% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -1048.119% |